Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | -3.05% | +0.63% | -77.92% |
May. 16 | AEON Biopharma, Inc. Announces Termination of Peter Reynolds as Chief Financial Officer, Effective May 17, 2024 | CI |
May. 16 | AEON Biopharma, Inc. Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-77.92% | 64.16M | |
+19.24% | 125B | |
+14.24% | 108B | |
-4.00% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-12.43% | 16.5B | |
+2.50% | 13.39B | |
+27.27% | 11.1B |
- Stock Market
- Equities
- AEON Stock
- News AEON Biopharma, Inc.
- AEON Biopharma Shares Slump Pre-Bell After Failed Chronic Migraine Phase 2 Trial